COMPASS THERAPEUTICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
COMPASS THERAPEUTICS, INC. (CMPX) had Common Stock, Capital Shares Reserved for Future Issuance of 4.21 million shares as of 2022-01-01, per its 10-K filed 2022-03-18.
Discontinued › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2022-03-18
- 2022-01-01: Common Stock, Capital Shares Reserved for Future Issuance 4.21M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2022-01-01 | 4.21M shares 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |